- Home
- COLD vs ROIV Comparison
COLD vs ROIV Comparison
Compare COLD & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | COLD | ROIV |
|---|---|---|
| Founded | 1903 | 2014 |
| Country | United States | United Kingdom |
| Employees | 12690 | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 20.7B |
| IPO Year | 2009 | 2021 |
Fundamental Metrics
Financial Performance| Metric | COLD | ROIV |
|---|---|---|
| Price | $11.57 | $27.77 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 8 |
| Target Price | $15.32 | ★ $27.56 |
| AVG Volume (30 Days) | ★ 4.6M | 4.6M |
| Earning Date | 05-07-2026 | 02-06-2026 |
| Dividend Yield | ★ 7.69% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,601,846,000.00 | $29,053,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.66 | $594.84 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.10 | $8.73 |
| 52 Week High | $22.10 | $30.33 |
Technical Indicators
Market Signals| Indicator | COLD | ROIV |
|---|---|---|
| Relative Strength Index (RSI) | 40.34 | 50.92 |
| Support Level | $10.31 | $26.94 |
| Resistance Level | $13.44 | $27.94 |
| Average True Range (ATR) | 0.42 | 0.96 |
| MACD | -0.08 | -0.36 |
| Stochastic Oscillator | 22.10 | 23.85 |
Price Performance
Historical ComparisonAbout COLD Americold Realty Trust Inc.
Americold Realty Trust Inc is the world's second-largest owner and operator of temperature-controlled warehouses behind privately held Lineage Logistics. The Atlanta, Georgia-based firm owns and operates approximately 231 temperature-controlled warehouses, spanning 1.4 billion cubic feet. In 2022, the firm derived more than 80% of its revenue from the United States but also has sizable operations in Europe, Canada, Australia, and New Zealand. Americold supplements its core business by providing supply management and transportation services to its various customers. It operates as a real estate investment trust.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.